Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
暂无分享,去创建一个
K. Havemann | A Gagro | G Dasić | A Sabioncello | S Rabatić | B Reckzeh | K Havemann | I Kardum | B Jacksić | B Vitale | A. Gagro | S. Rabatić | B. Reckzeh | A. Sabioncello | G. Dašić | I. Kardum | B. Vitale | B. Jacksić | Barbara Reckzeh | Klaus Havemann | Ika Kardum | Branimir Jakšić
[1] A. Rosén,et al. CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes , 1993, European journal of immunology.
[2] W. Gregory,et al. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia , 1987, British journal of haematology.
[3] E. Cronkite,et al. Clinical staging of chronic lymphocytic leukemia. , 1975, Blood.
[4] I Hannet,et al. Developmental and maturational changes in human blood lymphocyte subpopulations. , 1992, Immunology today.
[5] P. Debré,et al. Expression, structure, and function of the CD23 antigen. , 1991, Advances in immunology.
[6] S. Lewis,et al. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia , 1986, British journal of haematology.
[7] R. Bataille,et al. CD72 is constantly expressed in chronic lymphocytic leukemia and other B-cell lymphoproliferative disorders. , 1994, Leukemia research.
[8] D. Conrad,et al. The expression of B cell surface receptors. III. The murine low-affinity IgE Fc receptor is not expressed on Ly 1 or 'Ly 1-like' B cells. , 1991, International immunology.
[9] D. Bevan,et al. Decreased expression of complement receptor type 2 (CR2) on neoplastic B cells of chronic lymphocytic leukaemia , 1991, Clinical and experimental immunology.
[10] M. Cooper,et al. B-cell development in man. , 1993, Current opinion in immunology.
[11] J. Gordon,et al. B-cell signalling via the C-type lectins CD23 and CD72. , 1994, Immunology today.
[12] B. Jakšić,et al. Total Tumour Mass Score (TTM): a New Parameter in Chronic Lymphocytic Leukaemia , 1981, British journal of haematology.
[13] Marcos González,et al. B‐cell chronic lymphocytic leukaemia: Prognostic value of the immunophenotype and the clinico‐haematological features , 1989, American journal of hematology.
[14] F. Caligaris‐cappio. B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. , 1996, Blood.
[15] J. R. Smith,et al. Immunophenotypic subclassification of chronic lymphocytic leukaemia (CLL) , 1992, British journal of haematology.
[16] H. Gralnick,et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. , 1989, Journal of clinical pathology.
[17] D. Bevan,et al. Surface and Molecular Expression of Complement‐Receptor Type 2 of Neoplastic CD5+ B Cells in Chronic Lymphocytic Leukemia , 1992, Annals of the New York Academy of Sciences.
[18] A. Gagro,et al. CD21‐CD23 ligand pair expression in children with allergic asthma , 1993, Clinical and Experimental Immunology.
[19] D. Recktenwald,et al. A simultaneous three-color T cell subsets analysis with single laser flow cytometers using T cell gating protocol. Comparison with conventional two-color immunophenotyping method. , 1992, Journal of immunological methods.
[20] H. Nielsen,et al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. , 1991 .
[21] H. Velde,et al. The B-cell surface protein CD72/Lyb-2 is the ligand for CDS , 1991, Nature.
[22] C. Gasche,et al. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] J. Katzmann,et al. Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphocytic leukemia. , 1994, American journal of clinical pathology.
[24] J. Bonnefoy,et al. CD21 is a ligand for CD23 and regulates IgE production , 1992, Nature.
[25] S. Swendeman,et al. The activation antigen BLAST‐2, when shed, is an autocrine BCGF for normal and transformed B cells. , 1987, The EMBO journal.
[26] S. Fournier,et al. The Low‐Affinity Receptor for IgE , 1992, Immunological reviews.
[27] A. Tefferi,et al. Role of immunotyping in chronic lymphocytosis: review of the natural history of the condition in 145 adult patients. , 1988, Mayo Clinic proceedings.
[28] S. Korsmeyer,et al. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. , 1990, Journal of immunology.
[29] M. Sarfati. CD23 and chronic lymphocytic leukemia. , 1993, Blood cells.
[30] S. Fournier,et al. Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation. , 1994, Blood.
[31] D. Fearon. The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes. , 1993, Current opinion in immunology.